【New Product】 The company launches a series of culture media for stem cell osteogenesis, cartilage,

Stem cells and regenerative medicine are one of the future directions of medical development, and also provide unlimited possibilities for disease treatment. Multidirectional differentiation potential is one of the key characteristics of stem cells and one of the most commonly used techniques for in vitro and in vivo research on stem cells, including iPSC cells.

The core technology team of Joint Therapeutics Co., Ltd. has accumulated decades of experience in stem cell research and established efficient and stable human and mouse stem cell induction differentiation culture media, which can provide key technical support for industry colleagues. The series of culture media launched this time include osteogenic, cartilage, and adipose differentiation culture media.

The formula of this series of culture media is adopted by multiple top international laboratories, and the composition of the culture media has been improved and optimized by the company's technical team, which can achieve efficient and rapid differentiation efficiency of stem cells. At the same time, the company also provides downstream osteogenesis, cartilage, and adipose differentiation detection technology services and related reagents.

If you need to learn more about Joint Therapeutics Co., Ltd. and its independently developed products and technical services, please visit the company's official website or contact us.

Telephone: 010-53689023

E-mail: sales@penggegroup.com

Official Ｗebsite: www.penggegroup.com